Time for a proper study of aspirin after a vascular event?BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a2583 (Published 19 November 2008) Cite this as: BMJ 2008;337:a2583
- John G F Cleland, professor of cardiology1
- 1Castle Hill Hospital, University of Hull, Kingston upon Hull HU16 5JQ
Belch et al add to the documentation that long term aspirin has little or no benefit in patients who have or are at risk of atherosclerotic cardiovascular disease.1 2
Few long term trials of aspirin have shown a reduction in mortality or major morbidity. However, editors of journals persist in publishing papers on aspirin with conclusions designed to mislead health professionals and the public.
The New …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial